The costs of new treatments for cancer: the economics of reality

As regular readers will be aware, The “New” Prostate Cancer InfoLink regularly notes that the continuing rise in the prices of new drugs for the treatment of prostate cancer (and many other conditions too) is unsustainable. And what we need to do about it is hard to work out. … READ MORE …

Self-referral and the role of IMRT in treatment of prostate cancer

The issue of whether some urology practices are investing in equipment capable of delivering intensity-modulated radiation therapy (IMRT) with financial motives is back on the front burner again. … READ MORE …